These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
442 related articles for article (PubMed ID: 29158272)
1. Combination Antibiotic Exposure Selectively Alters the Development of Vancomycin Intermediate Resistance in Staphylococcus aureus. Zheng X; Berti AD; McCrone S; Roch M; Rosato AE; Rose WE; Chen B Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29158272 [TBL] [Abstract][Full Text] [Related]
2. Impact of cefazolin co-administration with vancomycin to reduce development of vancomycin-intermediate Staphylococcus aureus. Singh NB; Yim J; Jahanbakhsh S; Sakoulas G; Rybak MJ Diagn Microbiol Infect Dis; 2018 Aug; 91(4):363-370. PubMed ID: 29807674 [TBL] [Abstract][Full Text] [Related]
3. Vancomycin and piperacillin-tazobactam against methicillin-resistant Staphylococcus aureus and vancomycin-intermediate Staphylococcus aureus in an in vitro pharmacokinetic/pharmacodynamic model. Dilworth TJ; Leonard SN; Vilay AM; Mercier RC Clin Ther; 2014 Oct; 36(10):1334-44. PubMed ID: 25066667 [TBL] [Abstract][Full Text] [Related]
4. Exposure of Staphylococcus aureus to subinhibitory concentrations of β-lactam antibiotics induces heterogeneous vancomycin-intermediate Staphylococcus aureus. Roch M; Clair P; Renzoni A; Reverdy ME; Dauwalder O; Bes M; Martra A; Freydière AM; Laurent F; Reix P; Dumitrescu O; Vandenesch F Antimicrob Agents Chemother; 2014 Sep; 58(9):5306-14. PubMed ID: 24957836 [TBL] [Abstract][Full Text] [Related]
5. β-Lactam Combinations with Vancomycin Show Synergistic Activity against Vancomycin-Susceptible Staphylococcus aureus, Vancomycin-Intermediate S. aureus (VISA), and Heterogeneous VISA. Tran N; Rybak MJ Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29555635 [TBL] [Abstract][Full Text] [Related]
6. Synergistic effect of vancomycin combined with cefotaxime, imipenem, or meropenem against Staphylococcus aureus with reduced susceptibility to vancomycin. Srisrattakarn A; Chaiyapoke C; Booncharoen S; Wongthong S; Chanawong A; Tippayawat P; Tavichakorntrakool R; Lulitanond A Turk J Med Sci; 2021 Aug; 51(4):2150-2158. PubMed ID: 33705643 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of vancomycin in combination with piperacillin-tazobactam or oxacillin against clinical methicillin-resistant Staphylococcus aureus Isolates and vancomycin-intermediate S. aureus isolates in vitro. Dilworth TJ; Sliwinski J; Ryan K; Dodd M; Mercier RC Antimicrob Agents Chemother; 2014; 58(2):1028-33. PubMed ID: 24277036 [TBL] [Abstract][Full Text] [Related]
8. Prevalence of vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous VISA among methicillin-resistant S. aureus with high vancomycin minimal inhibitory concentrations in Taiwan: A multicenter surveillance study, 2012-2013. Huang SH; Chen YC; Chuang YC; Chiu SK; Fung CP; Lu PL; Wang LS; Wu TL; Wang JT J Microbiol Immunol Infect; 2016 Oct; 49(5):701-707. PubMed ID: 26320398 [TBL] [Abstract][Full Text] [Related]
9. In vivo development of daptomycin resistance in vancomycin-susceptible methicillin-resistant Staphylococcus aureus severe infections previously treated with glycopeptides. Capone A; Cafiso V; Campanile F; Parisi G; Mariani B; Petrosillo N; Stefani S Eur J Clin Microbiol Infect Dis; 2016 Apr; 35(4):625-31. PubMed ID: 26815434 [TBL] [Abstract][Full Text] [Related]
10. Analysis of synergy between beta-lactams and anti-methicillin-resistant Staphylococcus aureus agents from the standpoint of strain characteristics and binding action. Ono D; Yamaguchi T; Hamada M; Sonoda S; Sato A; Aoki K; Kajiwara C; Kimura S; Fujisaki M; Tojo H; Sasaki M; Murakami H; Kato K; Ishii Y; Tateda K J Infect Chemother; 2019 Apr; 25(4):273-280. PubMed ID: 30713034 [TBL] [Abstract][Full Text] [Related]
11. In vitro synergistic effects of various combinations of vancomycin and non-beta-lactams against Staphylococcus aureus with reduced susceptibility to vancomycin. Kang YR; Chung DR; Kim J; Baek JY; Kim SH; Ha YE; Kang CI; Peck KR; Song JH Diagn Microbiol Infect Dis; 2016 Nov; 86(3):293-299. PubMed ID: 27591174 [TBL] [Abstract][Full Text] [Related]